Warburg Pincus, KKR in talks to buy medical packaging maker Gerresheimer, Bloomberg News reports
A consortium consisting of Warburg Pincus and KKR are in talks to acquire German medical packaging maker Gerresheimer AG , ...
Litigation Trends to Watch: Claims Surge Over Corporate ‘Greenwashing,’ Toothpaste Contamination and AI-Driven Promises
Class actions are gaining momentum in the food and beverage sector, according to Law.com Radar. The platform surfaced 24 ...
pharmaphorum4d
The Ozempic dilemma: Balancing demand, supply, and patient safety in a viral GLP-1 world
Only three drugs – Novo Nordisk’s Wegovy and Saxenda ... of drugs with combinations of letters and numbers printed on the packaging, which are then used to track the product in a given ...
Verywell Health on MSN2d
Novo Nordisk Offers Wegovy for $499 a Month in Direct-to-Consumer Program
Novo Nordisk announced a direct-to-consumer program that allows patients to buy Wegovy out of pocket at a lower cost.
Pulmonology Advisor1d
Novo Nordisk Provides Direct-to-Patient Delivery Option for Wegovy
Novo Nordisk is providing direct-to-patient delivery of Wegovy (semaglutide) through the NovoCare Pharmacy program.
Yahoo Finance6d
Novo Nordisk CEO warns tariffs could send the prices of Ozempic and Wegovy higher
The CEO of <strong>Novo Nordisk</strong> warned of the impact of tariffs on the pharmaceutical industry. Weight-loss drugs, including Ozempic and Wegovy, could cost ...
Healio6d
NovoCare Pharmacy may improve access to Wegovy, but concerns about affordability remain
Adults with obesity who have a prescription for Wegovy but do not have insurance coverage for the drug can now purchase the ...
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
WBEZ6d
Consumers can buy Zepbound and Wegovy direct from drugmakers if they pay cash
Wegovy’s maker, Novo Nordisk, is charging $499 per month for its direct-to-consumer product. Customers can’t get their health insurance to pay for the either Eli Lilly’s Zepbound vials or ...